Skip to content
AnalystLens

CACI International Annual Report (Amendment), Year Ended Jun 30, 1994

Filing Date
Filed September 28, 1994
Period End
June 30, 1994
Security
CACI
In the record · 2016–202610-K1110-Q338-K122

CACI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’18May ’18
  2. Leadership change8-K · Jul ’20Jul ’20
  3. Auditor change8-K · Jun ’22Jun ’22
  4. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 10-K/A filed September 28, 1994. Cited figures are marked; the original filing is the authoritative source.

CACI International Inc, filing under its 1994 name, reported fiscal 1994 (year ended June 30, 1994) revenue of $183.7 milliona, up from $145.1 million in fiscal 1993, with net income of $6.04 million, or $0.57 per share, compared with $2.98 million, or $0.29 per share, a year earlier.

Income before income taxes and the extraordinary item was $10.23 millionb. Results were helped by the December 1993 acquisition of the Government Services business of SofTech, Inc., which added $13.8 million of fiscal 1994 revenue, and by growth in the U.K. operation. Federal government contracts made up 71% of business volume, and the Department of Justice litigation support contract accounted for 11.6% of fiscal 1994 revenue.

Total backlog at June 30, 1994 was $726.5 millionc, of which $77.2 million was firm. The balance sheet strengthened, with shareholders' equity rising to $37.7 million from $30.5 million and total assets reaching $71.0 million. Cash was only $941,000, and borrowings under a $20 million Signet Bank credit line fell to $2.7 million.

The company has never paid a cash dividend and does not intend to pay one in the foreseeable future. The main investor overhang is the settlement of the Pfirman and Chrysogelos shareholder suits. The settlement includes a contingent self-tender for 1.3 million shares at $6.00d per share, which applies only if the average closing price falls below $6.00 for twenty consecutive trading days between July 22, 1994 and February 28, 1995.

The company said that if the tender is fully subscribed, debt would increase by about $7.8 million and equity would fall by a similar amount. The stock was trading well above $6.00 as of August 31, 1994. A Delaware Chancery Court hearing on the settlement was set for November 15, 1994, and the company is also pursuing litigation against Pentagen Technologies International, Ltd.

Key Highlights

  1. Fiscal 1994 revenue rose to $183.7 million from $145.1 million, an increase of 26.6%.
  2. Net income was $6.04 million, or $0.57 per share, versus $2.98 million, or $0.29 per share, in fiscal 1993.
  3. Federal government contracts were 71% of business volume; DoD accounted for 51% of revenue and DoJ for 15.7%.
  4. Backlog was $726.5 million at June 30, 1994, of which $77.2 million was firm, compared with $570 million total backlog a year earlier.
  5. Shareholders' equity increased to $37.7 million, and total assets reached $71.0 million at June 30, 1994.
  6. A contingent self-tender for 1.3 million shares at $6.00 per share could add about $7.8 million to debt if fully subscribed.
  7. The company has never paid a cash dividend and does not intend to pay one in the foreseeable future.

Frequently Asked Questions

  1. What drove the revenue growth in fiscal 1994?

    Revenue rose $38.6 million to $183.7 million. The DoD revenue increase of $15.5 million was primarily due to the December 1993 SofTech Government Services acquisition, which added $13.8 million of fiscal 1994 revenue. DoJ revenue rose $8.3 million on new litigation support contracts, and commercial revenue rose $8.7 million, with U.K. revenue up 48%.

  2. What is the shareholder litigation settlement and how could it affect the company?

    The Pfirman and Chrysogelos suits were settled subject to Delaware Chancery Court approval, with a hearing set for November 15, 1994. The settlement includes a $600,000 fund for class members who sold shares at a loss between April 26 and December 1, 1990, and a contingent self-tender for 1.3 million shares at $6.00 per share. The tender occurs only if the stock averages below $6.00 over twenty consecutive trading days before February 28, 1995. The company said the stock was substantially above $6.00 as of August 31, 1994.

  3. How strong is the company's liquidity?

    Cash and equivalents were $941,000 at June 30, 1994. Borrowings under the $20 million Signet Bank line of credit were $2.7 million, down from $7.2 million a year earlier. Net cash provided by operating activities was $9.1 million. Management believes internally generated funds, bank credit and cash on hand will provide sufficient liquidity for the foreseeable future.

  4. What is the status of the Pentagen litigation?

    On June 16, 1994, the Eastern District of Virginia court ruled in CACI's favor on several copyright and trademark claims, held Pentagen liable for tortious interference, and held Pentagen and two principals liable for defamation per se. CACI was awarded $110,550 in attorneys' fees, $61,500 in court costs and $11,000 in damages. The defendants have appealed, and the New York cases remain pending. Management does not expect a material adverse effect on the financial statements.

  5. Is the company dependent on a few contracts?

    Yes, in part. The ten largest revenue-producing contracts accounted for 42% of revenue, or $76.8 million. A single DoJ automated litigation support contract accounted for 11.6% of total fiscal 1994 revenue. The company is seeking to diversify away from DoD work, though DoD revenue grew 20% in fiscal 1994.